Dermapharm Holding SE (ETR:DMP)

Dermapharm Holding SE Income Statement

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Operating Revenue	1,190	1,195	1,150	1,040	959.6	807.64
Other Revenue	11.36	0.75	0.42	0.25	0.49	0.67
Revenue	1,202	1,195	1,151	1,041	960.09	808.31
Revenue Growth (YoY)	4.79%	3.89%	10.59%	8.38%	18.78%	13.15%
Cost of Revenue	435.33	445.6	446.6	391.85	349.87	354.42
Gross Profit	766.26	749.85	704.14	648.7	610.22	453.89
Selling, General & Admin	295.09	287.43	271.01	190.56	168.95	158.06
Other Operating Expenses	151.72	158.18	151.21	117.72	99.68	110.13
Operating Expenses	525.74	527.78	510.99	365.98	314.31	313.77
Operating Income	240.52	222.07	193.16	282.72	295.91	140.12
Interest Expense	-57.75	-58.41	-54.97	-12.34	-8.84	-9.36
Interest & Investment Income	-	13.99	2.49	0.33	4.02	0.51
Earnings From Equity Investments	1.33	1.52	-7.16	-13.54	0.32	-1.5
Currency Exchange Gain (Loss)	1.4	1.4	-1.95	0.37	2.28	-1.63
Other Non Operating Income (Expenses)	-14.35	-0.96	-16.63	-1.12	-0.83	0.24
EBT Excluding Unusual Items	171.15	179.61	114.93	256.43	292.86	128.38
Merger & Restructuring Charges	-	-	-	-	-0.6	-
Impairment of Goodwill	-2.12	-2.12	-	-36.45	-5.43	-
Gain (Loss) on Sale of Investments	-0	-0	-1.98	-	9.06	-
Gain (Loss) on Sale of Assets	0.63	0.63	2.96	3.13	1.38	0.23
Asset Writedown	-6.21	-6.21	-15.82	-7.03	-4.48	-3.58
Other Unusual Items	-	-	5.78	-	-	-
Pretax Income	163.55	172.01	106	216.3	292.98	125.28
Income Tax Expense	57.64	60.27	45.46	83.68	84.07	39.36
Earnings From Continuing Operations	105.91	111.74	60.53	132.62	208.9	85.93
Minority Interest in Earnings	1.29	2.05	1.83	1.62	0.68	-0.1
Net Income	107.2	113.79	62.37	134.24	209.58	85.83
Net Income to Common	107.2	113.79	62.37	134.24	209.58	85.83
Net Income Growth	29.10%	82.45%	-53.54%	-35.95%	144.19%	11.18%
Shares Outstanding (Basic)	54	54	54	54	54	54
Shares Outstanding (Diluted)	54	54	54	54	54	54
Shares Change (YoY)	-0.40%	-	-	-	-	-
EPS (Basic)	1.99	2.11	1.16	2.49	3.89	1.59
EPS (Diluted)	1.99	2.11	1.16	2.49	3.89	1.59
EPS Growth	29.61%	82.45%	-53.54%	-35.91%	144.65%	11.19%
Free Cash Flow	175.35	163.14	177.88	249.52	189.17	90.3
Free Cash Flow Per Share	3.26	3.03	3.30	4.63	3.51	1.68
Dividend Per Share	0.900	0.900	0.880	1.050	2.170	0.880
Dividend Growth	2.27%	2.27%	-16.19%	-51.61%	146.59%	10.00%
Gross Margin	63.77%	62.72%	61.19%	62.34%	63.56%	56.15%
Operating Margin	20.02%	18.58%	16.79%	27.17%	30.82%	17.34%
Profit Margin	8.92%	9.52%	5.42%	12.90%	21.83%	10.62%
Free Cash Flow Margin	14.59%	13.65%	15.46%	23.98%	19.70%	11.17%
EBITDA	267.29	250.77	220.31	302.36	312.36	155.05
EBITDA Margin	22.24%	20.98%	19.14%	29.06%	32.53%	19.18%
D&A For EBITDA	26.77	28.7	27.15	19.64	16.45	14.92
EBIT	240.52	222.07	193.16	282.72	295.91	140.12
EBIT Margin	20.02%	18.58%	16.79%	27.17%	30.82%	17.34%
Effective Tax Rate	35.24%	35.04%	42.89%	38.69%	28.70%	31.41%

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.